Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Combination of an anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases
No-Receipt date
2017-02183 - 26/06/2017
No-Filing date
20170401735 - 26/06/2017
No-Granting date
3092892 - 07/09/2017
No-EPO application date
14162613.5 - 29/10/2009
No-EPO granting date
2769737 - 05/04/2017
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
9/2017 - 22/11/2017
Expiration date
30/10/2029
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US226910 P20/07/2009/US
US46216830/07/2009/US
WOPCT/US2009/05220930/07/2009/WO
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07K 16/28
A61K 45/06
A61K 39/395
A61K 39/00
A61K 33/24
A61K 31/506
A61K 31/385
A61K 31/337
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
775476
BRISTOL-MYERS SQUIBB COMPANY
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1910091
LEE, FRANCIS, Y.
1910092
JURE-KUNKEL, MARIA
Representatives
Code
Firstname
Surname
Address
Town
Zip
3554
ANTHOULA
GALANOPOULOU
DIONYSOU 68
MAROUSI (ATTIKIS)
15124
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2897
ALKISTIS-EIRINI
MALAMI
SKOUFA 52
ATHINA (ATTIKIS)
10672
GREECE
Owners History
Title Instruments
Payments history
16 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).